Calella, Spain

Carles Ferrer Costa

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Medicis Pharmaceutical Corporation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carles Ferrer Costa. Retrieved from https://idiyas.com/inventor/carles-ferrer-costa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carles Ferrer Costa: Innovator in Histamine H4 Receptor Antagonists

Introduction

Carles Ferrer Costa is a notable inventor based in Calella, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target histamine receptors. His work is characterized by a focus on innovative solutions that address medical needs.

Latest Patents

Carles Ferrer Costa holds a patent for "Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists." This patent describes aminoalkylpyrimidine derivatives of formula I, where the meanings of the different substituents are detailed in the description. These compounds are recognized for their utility as histamine H4 receptor antagonists, which can have important implications in treating various conditions.

Career Highlights

Throughout his career, Carles has been associated with Medicis Pharmaceutical Corporation, where he has contributed to the advancement of pharmaceutical research and development. His expertise in medicinal chemistry has positioned him as a valuable asset in the industry.

Collaborations

Carles has worked alongside Elena Carceller Gonzalez, collaborating on projects that aim to enhance the understanding and application of histamine receptor antagonists. Their combined efforts reflect a commitment to innovation in the pharmaceutical sector.

Conclusion

Carles Ferrer Costa's work in developing histamine H4 receptor antagonists showcases his dedication to advancing medical science. His contributions through patents and collaboration highlight the importance of innovation in addressing healthcare challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…